FATE vs IRM · rev $13.6M vs P/E 136, rev $6.15B
Fate Therapeutics Inc (FATE) versus Iron Mountain Incorporated (IRM) — a side-by-side from cached financials, not a winner call.
Fate Therapeutics Inc (FATE) is a biotechnology company listed on US.
Iron Mountain Incorporated (IRM) is a reit - specialty company listed on US.
Latest reported FATE revenue for 2024-12-31 was $13.6M. Net income was -$186.3M. Revenue was down 78.5% from 2023-12-31 to 2024-12-31. FATE currently screens at market cap $331.0M.
Latest reported IRM revenue for 2024-12-31 was $6.15B. Net income was $183.7M. Revenue was up 12.2% from 2023-12-31 to 2024-12-31. IRM currently screens at market cap $37.09B and trailing P/E 135.5.
FATE currently screens at market cap $331.0M. IRM currently screens at market cap $37.09B and trailing P/E 135.5.
Not investment advice. Open the FATE and IRM stock pages for the full models.
Not investment advice.